Ma. Fatima Francisco Procter & Gamble CO (PG) insider trading activity

Ma. Fatima Francisco is CEO - Baby, Fem & Family Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 13,727 shares of PG, which is worth approximately $2.32 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 58 shares (Common Stock) at a price of $169.79 per share, resulting in proceeds of $9,847. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K

0.04% 3M change

23.37% 12M change

Total Value Held $2.32 Million

Ma. Fatima Francisco Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2024	SELL Payment of exercise price or tax liability	$9,847 $169.79 p/Share	58 Reduced 0.42%	13,727 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	$9,847 $169.79 p/Share	58 Added 0.42%	13,785 Common Stock
Aug 22 2024	SELL Open market or private sale	$16,320,000 $170.0 p/Share	96,000 Reduced 87.49%	13,721 Common Stock
Aug 22 2024	BUY Exercise of conversion of derivative security	$9,460,800 $98.55 p/Share	96,000 Added 46.67%	109,721 Common Stock
Aug 20 2024	SELL Open market or private sale	$1,665,801 $169.22 p/Share	9,844 Reduced 41.77%	13,721 Common Stock
Aug 19 2024	BUY Grant, award, or other acquisition	-	22,068 Added 48.37%	23,559 Common Stock
May 08 2024	SELL Open market or private sale	$334,510 $166.01 p/Share	2,015 Reduced 57.57%	1,485 Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	$248,543 $98.55 p/Share	2,522 Added 41.88%	3,500 Common Stock
Feb 23 2024	SELL Open market or private sale	$3,272,003 $161.0 p/Share	20,323 Reduced 95.41%	978 Common Stock
Feb 23 2024	BUY Exercise of conversion of derivative security	$1,595,761 $78.52 p/Share	20,323 Added 48.83%	21,301 Common Stock
Feb 06 2024	SELL Open market or private sale	$3,975,000 $159.0 p/Share	25,000 Reduced 96.25%	973 Common Stock
Feb 06 2024	BUY Exercise of conversion of derivative security	$1,963,000 $78.52 p/Share	25,000 Added 49.05%	25,973 Common Stock
Jan 29 2024	SELL Open market or private sale	$7,020,000 $156.0 p/Share	45,000 Reduced 97.88%	973 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	$3,533,400 $78.52 p/Share	45,000 Added 49.47%	45,973 Common Stock
Jan 24 2024	SELL Open market or private sale	$11,431,467 $153.56 p/Share	74,443 Reduced 98.71%	973 Common Stock
Jan 24 2024	BUY Exercise of conversion of derivative security	$5,854,799 $91.07 p/Share	64,289 Added 49.62%	65,262 Common Stock
Dec 06 2023	SELL Payment of exercise price or tax liability	$8,366 $149.4 p/Share	56 Reduced 0.5%	11,127 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$8,366 $149.4 p/Share	56 Added 0.5%	11,183 Common Stock
Aug 17 2023	SELL Open market or private sale	$1,262,235 $152.85 p/Share	8,258 Reduced 42.61%	11,121 Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	18,412 Added 48.72%	19,379 Common Stock
Aug 09 2023	SELL Open market or private sale	$4,740,300 $158.01 p/Share	30,000 Reduced 96.9%	961 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$2,732,100 $91.07 p/Share	30,000 Added 49.21%	30,961 Common Stock
Aug 01 2023	SELL Open market or private sale	$1,315,668 $156.87 p/Share	8,387 Reduced 89.72%	961 Common Stock
Apr 24 2023	SELL Open market or private sale	$1,254,720 $156.84 p/Share	8,000 Reduced 46.13%	9,343 Common Stock
Dec 07 2022	SELL Payment of exercise price or tax liability	$8,652 $149.18 p/Share	58 Reduced 0.33%	17,337 Common Stock

Also insider at

HPQ

HP INC Technology

OGN

Organon & Co. Healthcare

Director

MFF